Mechanisms of pulmonary fibrosis: role of activated myofibroblasts and NADPH oxidase
- PMID: 23259497
- PMCID: PMC3368794
- DOI: 10.1186/1755-1536-5-S1-S23
Mechanisms of pulmonary fibrosis: role of activated myofibroblasts and NADPH oxidase
Abstract
A common feature of pathological fibrosis involving the lung and other organs is the persistent activation of myofibroblasts in injured tissues. Recent evidence supports the role of a member of the NADPH oxidase (NOX) gene family, NOX4, in myofibroblast differentiation, matrix synthesis and contractility. Additionally, NOX4 may contribute directly or indirectly to alveolar epithelial cell death, while myofibroblasts themselves acquire an apoptosis-resistant phenotype. Thus, NOX4 may be responsible for the cardinal features of progressive fibrosis - myofibroblast activation and epithelial cell dysrepair. Therapeutic targeting of NOX4 is likely to be effective in progressive cases of fibrosis involving multiple organs.
Figures
Similar articles
-
Targeting of NADPH oxidase in vitro and in vivo suppresses fibroblast activation and experimental skin fibrosis.Exp Dermatol. 2017 Jan;26(1):73-81. doi: 10.1111/exd.13180. Exp Dermatol. 2017. PMID: 27576129
-
An inhibitor of NADPH oxidase-4 attenuates established pulmonary fibrosis in a rodent disease model.Am J Respir Cell Mol Biol. 2014 Jan;50(1):158-69. doi: 10.1165/rcmb.2013-0174OC. Am J Respir Cell Mol Biol. 2014. PMID: 23977848
-
Signalling pathways from NADPH oxidase-4 to idiopathic pulmonary fibrosis.Int J Biochem Cell Biol. 2011 Aug;43(8):1086-9. doi: 10.1016/j.biocel.2011.04.003. Epub 2011 Apr 12. Int J Biochem Cell Biol. 2011. PMID: 21513813 Review.
-
Myofibroblast differentiation during fibrosis: role of NAD(P)H oxidases.Kidney Int. 2011 May;79(9):944-56. doi: 10.1038/ki.2010.516. Epub 2011 Feb 9. Kidney Int. 2011. PMID: 21307839 Free PMC article. Review.
-
NOX4/NADPH oxidase expression is increased in pulmonary fibroblasts from patients with idiopathic pulmonary fibrosis and mediates TGFbeta1-induced fibroblast differentiation into myofibroblasts.Thorax. 2010 Aug;65(8):733-8. doi: 10.1136/thx.2009.113456. Thorax. 2010. PMID: 20685750 Free PMC article.
Cited by
-
Therapeutic Approaches for the Treatment of Interstitial Lung Disease: An Exploratory Review on Molecular Mechanisms.Mini Rev Med Chem. 2024;24(6):618-633. doi: 10.2174/1389557523666230816090112. Mini Rev Med Chem. 2024. PMID: 37587813 Review.
-
The Hexosamine Biosynthetic Pathway Links Innate Inflammation With Epithelial-Mesenchymal Plasticity in Airway Remodeling.Front Pharmacol. 2021 Dec 22;12:808735. doi: 10.3389/fphar.2021.808735. eCollection 2021. Front Pharmacol. 2021. PMID: 35002741 Free PMC article. Review.
-
Nanoapproaches to Modifying Epigenetics of Epithelial Mesenchymal Transition for Treatment of Pulmonary Fibrosis.Front Pharmacol. 2020 Dec 11;11:607689. doi: 10.3389/fphar.2020.607689. eCollection 2020. Front Pharmacol. 2020. PMID: 33384604 Free PMC article. Review.
-
Type I Collagen Signaling Regulates Opposing Fibrotic Pathways through α2β1 Integrin.Am J Respir Cell Mol Biol. 2020 Nov;63(5):613-622. doi: 10.1165/rcmb.2020-0150OC. Am J Respir Cell Mol Biol. 2020. PMID: 32692932 Free PMC article.
-
CCL5 promotes breast cancer recurrence through macrophage recruitment in residual tumors.Elife. 2019 Apr 16;8:e43653. doi: 10.7554/eLife.43653. Elife. 2019. PMID: 30990165 Free PMC article.
References
LinkOut - more resources
Full Text Sources
Other Literature Sources